Literature DB >> 19428957

Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells.

C Kaur1, E A Ling.   

Abstract

Periventricular white matter damage (PWMD) also known as periventricular white matter injury, is one of the major causes of neurological impairment in premature newborns. The etiology of white matter injury is multifaceted with hypoxia-ischemia being an important underlying factor. The developing oligodendrocytes are susceptible to damage resulting in myelination deficits. Excess release of glutamate, free radical production, release of cytokines and iron accumulation are factors thought to mediate damage to the developing white matter. Recent studies have also suggested a role for vascular endothelial growth factor and nitric oxide in the pathogenesis of PWMD. Although the role of microglial cells in the development of PWMD is still debatable, our recent investigations have shed some light on their involvement in the pathogenesis of PWMD. Challenges for the future include in-depth investigation of crosstalk between microglia and immature oligodendrocytes as well as other glial cells and vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428957     DOI: 10.1016/j.pneurobio.2009.01.003

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  45 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

Review 2.  The premature brain: developmental and lesional anatomy.

Authors:  Charles Raybaud; Tahani Ahmad; Neda Rastegar; Manohar Shroff; Mutaz Al Nassar
Journal:  Neuroradiology       Date:  2013-07-07       Impact factor: 2.804

3.  Capsaicin pre-treatment provides neurovascular protection against neonatal hypoxic-ischemic brain injury in rats.

Authors:  Nikan H Khatibi; Vikram Jadhav; Shelton Charles; Jeffrey Chiu; John Buchholz; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2011

Review 4.  Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.

Authors:  Charanjit Kaur; Gurugirijha Rathnasamy; Eng-Ang Ling
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-26       Impact factor: 4.147

5.  Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.

Authors:  Govindaiah Vinukonda; Anna Csiszar; Furong Hu; Krishna Dummula; Nishi Kant Pandey; Muhammad T Zia; Nicholas R Ferreri; Zoltan Ungvari; Edmund F LaGamma; Praveen Ballabh
Journal:  Brain       Date:  2010-05-20       Impact factor: 13.501

Review 6.  Pathogenesis of cerebral palsy through the prism of immune regulation of nervous tissue homeostasis: literature review.

Authors:  Natalya Lisovska; Zholtay Daribayev; Yevgeny Lisovskyy; Kenzhe Kussainova; Lana Austin; Sholpan Bulekbayeva
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

7.  Association between neonatal iron overload and early human brain development in premature infants.

Authors:  Sanjiv B Amin; Gary Myers; Hongyue Wang
Journal:  Early Hum Dev       Date:  2012-02-18       Impact factor: 2.079

Review 8.  Cognitive Effects of Air Pollution Exposures and Potential Mechanistic Underpinnings.

Authors:  J L Allen; C Klocke; K Morris-Schaffer; K Conrad; M Sobolewski; D A Cory-Slechta
Journal:  Curr Environ Health Rep       Date:  2017-06

9.  Perinatal inflammation results in decreased oligodendrocyte numbers in adulthood.

Authors:  Amanda E Graf; Krista M Haines; Christopher R Pierson; Brad N Bolon; Ronald H Houston; Markus Velten; Kathryn M Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2013-11-28       Impact factor: 5.037

10.  Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate.

Authors:  Yingyan Wang; Baomin Li; Zhen Li; Shanying Huang; Jiwen Wang; Ruopeng Sun
Journal:  Neurochem Res       Date:  2013-03-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.